Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine as Adjunct to Mood Stabilizers in Bipolar I Maintenance
NCT00081380Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Mar 2004
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in bipolar I disorder comparing Quetiapine + Mood Stabilizer with Placebo + Mood Stabilizer (2 arms). Primary endpoint: Time to recurrence of a mood event. Started Mar 2004; status: completed.
02
Drugs
quetiapine
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT00081380.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00081380.